Abstract |
Aspirin is a common preventative therapy in patients at risk for cardiovascular diseases, yet little is known about how aspirin protects the vasculature in hypercholesterolemia. The present study determines whether aspirin, nitric oxide-releasing aspirin (NCX-4016), a selective cyclooxygenase (COX)-1 inhibitor ( SC560), or genetic deficiency of COX-1 prevents the inflammatory and prothrombogenic phenotype assumed by hypercholesterolemic (HC) venules. Aspirin or NCX-4016 (60 mg/kg) was administered orally for the last week of a 2-wk HC diet. COX-1-deficient (COX-1(-/-)) and wild-type (WT) mice were transplanted with WT (WT/COX-1(-/-)) or COX-1(-/-) (COX-1(-/-)/WT) bone marrow, respectively. HC-induced adhesion of platelets and leukocytes in murine intestinal venules, observed with intravital fluorescence microscopy, was greatly attenuated in aspirin-treated mice. Adhesion of aspirin-treated platelets in HC venules was comparable to untreated platelets, whereas adhesion of SC560-treated platelets was significantly attenuated. HC-induced leukocyte and platelet adhesion in COX-1(-/-)/WT chimeras was comparable to that in SC560-treated mice, whereas the largest reductions in blood cell adhesion were in WT/COX-1(-/-) chimeras. NCX-4016 treatment of platelet recipients or donors attenuated leukocyte and platelet adhesion independent of platelet COX-1 inhibition. Platelet- and endothelial cell-associated COX-1 promote microvascular inflammation and thrombogenesis during hypercholesterolemia, yet nitric oxide-releasing aspirin directly inhibits platelets independent of COX-1.
|
Authors | Anitaben Tailor, Katherine C Wood, John L Wallace, Robert D Specian, D Neil Granger |
Journal | American journal of physiology. Heart and circulatory physiology
(Am J Physiol Heart Circ Physiol)
Vol. 293
Issue 6
Pg. H3636-42
(Dec 2007)
ISSN: 0363-6135 [Print] United States |
PMID | 17933963
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Cholesterol, Dietary
- Cyclooxygenase Inhibitors
- Membrane Proteins
- Nitric Oxide Donors
- Pyrazoles
- SC 560
- Cyclooxygenase 1
- Ptgs1 protein, mouse
- nitroaspirin
- Aspirin
|
Topics |
- Animals
- Aspirin
(analogs & derivatives, pharmacology, therapeutic use)
- Blood Platelets
(drug effects, enzymology)
- Bone Marrow Transplantation
- Cardiovascular Diseases
(enzymology, etiology, physiopathology, prevention & control)
- Cell Adhesion
(drug effects)
- Chimera
(metabolism)
- Cholesterol, Dietary
- Cyclooxygenase 1
(deficiency, genetics, metabolism)
- Cyclooxygenase Inhibitors
(pharmacology, therapeutic use)
- Disease Models, Animal
- Endothelial Cells
(drug effects, enzymology)
- Endothelium, Vascular
(drug effects, enzymology, physiopathology)
- Hypercholesterolemia
(chemically induced, complications, drug therapy, enzymology, physiopathology)
- Leukocytes
(drug effects)
- Male
- Membrane Proteins
(deficiency, genetics, metabolism)
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Microscopy, Fluorescence
- Microscopy, Video
- Nitric Oxide Donors
(pharmacology, therapeutic use)
- Platelet Adhesiveness
(drug effects)
- Pyrazoles
(pharmacology, therapeutic use)
- Venules
(drug effects, enzymology)
|